Amphastar Pharmaceuticals IncAmphastar Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

If you work at Amphastar Pharmaceuticals Inc and you wish to licence your ESG aseessment, please get in touch. The report of Amphastar Pharmaceuticals Inc is assembled by All Street Sevva using proprietary artificial intelligence. Other companies in the rating industry group for Amphastar Pharmaceuticals Inc are displayedin the table.

Amphastar Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.2; made up of an environmental score of 6.0, social score of 4.8 and governance score of 4.8.

SDG Transparency Score for Amphastar Pharmaceuticals Inc 
Low
0 - 3

5.2

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2024-05-01
What drives the score for Amphastar Pharmaceuticals Inc 
6.0

Environmental

4.8

Social

4.8

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Caladrius Biosciences Inc
8.0
High
1Can Fite Biopharma Ltd
8.0
High
658Transchem Ltd
5.3
High
658Zenith Healthcare Ltd
5.3
High
687Amphastar Pharmaceuticals Inc
5.2
High
687Cardiol Therapeutics Inc
5.2
High
687Cell Source Inc
5.2
High
.........
1970Zyden Gentec Ltd
0.0
Low
1970iNtRON Biotechnology Inc
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Amphastar Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc offer flexible work?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose water use targets?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Amphastar Pharmaceuticals Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Amphastar Pharmaceuticals Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Amphastar Pharmaceuticals Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose its waste policy?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose energy use targets?

LockedSign up for free to unlock

Does Amphastar Pharmaceuticals Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Amphastar Pharmaceuticals Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Amphastar Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.

Amphastar Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Enoxaparin, a low molecular weight heparin to prevent and treat deep vein thrombosis; Naloxone for opioid overdose; Glucagon for injection emergency kit; and Cortrosyn, a lyophilized powder for use as a diagnostic agent in the screening of patients with adrenocortical insufficiency. The company also provides Amphadase, a bovine-sourced hyaluronidase injection to absorb and disperse other injected drugs; Epinephrine injection for the emergency treatment of allergic reactions; lidocaine jelly, an anesthetic product for urological procedures; lidocaine topical solution for various procedures; phytonadione injection, a vitamin K1 injection for newborn babies; emergency syringe products for emergency use in hospital settings; morphine injection for use with patient controlled analgesia pumps; and lorazepam injection for surgery and medical procedures. In addition, it offers procainamide for documented ventricular arrhythmias; neostigmine methylsulfate injection to treat myasthenia gravis and to reverse the effects of muscle relaxants; medroxyprogesterone acetate injectable suspension for the prevention of pregnancy; and Isoproterenol hydrochloride injection for mild or transient episodes of heart block, as well as manufactures and distributes recombinant human insulin active pharmaceutical ingredients (API) and porcine insulin API. It serves hospitals, care facilities, alternate care sites, clinics, and doctors' offices. The company was founded in 1996 and is headquartered in Rancho Cucamonga, California.

Sorry!

Failed to process!